Ovranette

You should take one Ovranette pill at the same time every day for 21 days, followed by a 7-day break where you don't take any pills. Start the next pack after the break, even if your period hasn't finished. If you forget a pill, take it as soon as you remember, even if this means taking two pills in one day. If you vomit within 2 hours of taking a pill, it may not be fully absorbed, so take another pill. Ovranette does not protect you from sexually transmitted infections. If you experience severe abdominal pain, chest pain, or shortness of breath, seek medical help immediately.  

Each Ovranette pill contains 150 micrograms of levonorgestrel and 30 micrograms of ethinylestradiol. The other ingredients are lactose, maize starch, povidone, magnesium stearate, sucrose, macrogol 6000, calcium carbonate, talc, montan glycol wax, titanium dioxide (E171), glycerol, ferric oxide pigment, and red ferric oxide pigment. 

Common side effects of Ovranette include nausea, headaches, breast tenderness, and changes in mood or libido. Serious side effects that require immediate medical attention include chest pain, swelling in the legs, difficulty breathing, and severe allergic reactions like rash, itching, or swelling.  

Do not take Ovranette if you have a history of blood clots, certain cancers, liver disease, or uncontrolled high blood pressure. It is not suitable for women over 35 who smoke or are obese. If you have a family history of blood clots or breast cancer, speak to your healthcare provider before starting Ovranette. If you are on medication for epilepsy, tuberculosis, or HIV, Ovranette may interact with these drugs, so consult your doctor before use. 

John Wyeth and Brother Ltd, 1995, Maidenhead, UK, Ovranette Patient Information Leaflet, Retrieved from http://mcs.open.ac.uk/nlg/old_projects/pills/corpus/PIL/data/Wyeth/Ovranette/Ovranette.html 

Pfizer Limited, 2018, Kent, United Kingdom, Ovranette 150 micrograms/30 micrograms coated tablets, Retrieved from https://www.medicines.org.uk/emc/files/pil.1524.pdf  

Pfizer Limited, 2018, United Kingdom, Ovranette 150/30 micrograms coated tablets, Retrieved from https://www.medicines.org.uk/emc/product/1524/smpc